Work

A Phase I Study of Selinexor in Combination with Daunorubicin and Cytarabine in Patients with Newly Diagnosed Poor-Risk Acute Myeloid Leukemia

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.4040.4040

Authors: Kendra L. Sweet, Rami S. Komrokji, Eric Padron, Christopher L Cubitt, Leyla Khavarian, Alan F List, David Sallman, Daniel Sullivan, Julio C Chavez, Bijal D. Shah, Jeffrey E. Lancet

Institution: Moffitt Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2729664746

FWCI: 1.267

Cites:

Cited by: 6

Related to: 10